Difference between revisions of "CT Coordinating Committee"
Jump to navigation
Jump to search
m |
|||
Line 2: | Line 2: | ||
Co-Chairs: Andrew J. Buckler, MS, PhD; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD | Co-Chairs: Andrew J. Buckler, MS, PhD; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD | ||
− | + | ||
* [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster'''] | * [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster'''] | ||
Revision as of 18:44, 21 December 2023
Co-Chairs: Andrew J. Buckler, MS, PhD; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
Scope
The CT Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of CT Biomarker Committees
- QIBA Profile Dashboard (CT Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
-
- Lung Density Biomarker Ctte
- CT Small Lung Nodule Biomarker Committee - [page: https://qibawiki.rsna.org/index.php/CT_Small_Lung_Nodule_Biomarker_Ctte]
- CT Angiography Biomarker Committee - [page: https://qibawiki.rsna.org/index.php/CT_Angiography_Biomarker_Ctte]
Meetings
- Zoom calls are held Quarterly. Please contact RSNA Staff for details.